DNA Link Inc. | Cash Flow

Fiscal year is January-December. All values KRW Millions.
2013
2014
2015
2016
2017
Net Income before Extraordinaries
7,211
4,459
9,054
9,811
338
Depreciation, Depletion & Amortization
1,947
2,579
2,997
3,065
1,799
Other Funds
78
90
-
-
-
Funds from Operations
3,260
30
3,584
2,469
1,514
Changes in Working Capital
2,982
174
145
1,301
4,004
Net Operating Cash Flow
278
143
3,729
3,770
2,490
Capital Expenditures
1,806
2,535
4,152
2,922
976
Sale of Fixed Assets & Businesses
-
-
4
-
475
Purchase/Sale of Investments
680
4,039
6,617
2,844
6,156
Net Investing Cash Flow
1,126
1,504
13,131
762
6,155
Issuance/Reduction of Debt, Net
857
844
15,000
1,573
2,573
Net Financing Cash Flow
935
754
20,873
1,573
1,573
Net Change in Cash
2,340
652
3,970
3,011
2,075
Free Cash Flow
1,919
1,567
7,279
5,118
3,243
Net Assets from Acquisitions
-
-
-
134
-
Other Sources
-
-
-
96
500
Change in Capital Stock
-
-
5,873
-
1,000
Exchange Rate Effect
1
46
43
53
16
Other Uses
-
-
2,366
646
-

About DNA Link

View Profile
Address
2nd Floor, Cluster Center
Seoul SL 03760
Korea, Republic Of
Employees -
Website http://www.dnalink.com
Updated 09/14/2018
DNA Link, Inc. provides genomic analysis services. Its services include next generation sequencing, microarray, genotyping, patient-derived xenograft, AccuID, and DNA genomics personalized service. The company was founded on March 15, 2000 and is headquartered in Seoul, South Korea.